The American Journal of Managed Care

Patients and Parents Impacted by SMA May Be Optimistic About Prenatal Testing, Therapies

As the feasibility of phase 1 clinical trials for prenatal spinal muscular atrophy (SMA) therapies is explored, patient and parent input on prenatal testing and possibly treatment is a valuable tool ...
Nasdaq

Biogen and Invitae Announce Availability of Rapid Results in Genetic Testing Program for ...

CAMBRIDGE, Mass. and SAN FRANCISCO, Aug. 20, 2019 (GLOBE NEWSWIRE) -- Biogen Inc. (Nasdaq: BIIB) and Invitae Corporation (NYSE: NVTA) today announced that SMA STAT, a new, rapid-turnaround genetic ...